Butador 10 mg/ml Solution for Injection for Horses, Dogs and Cats
Butador 10 mg/ml Solution for Injection for Horses, Dogs and Cats
Authorised
- Butorphanol tartrate
Product identification
Medicine name:
Butomidor 10 mg/ml Injektionslösung für Pferde, Hunde und Katzen
Butador 10 mg/ml Solution for Injection for Horses, Dogs and Cats
Active substance:
- Butorphanol tartrate
Target species:
-
Dog
-
Horse
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Butorphanol tartrate14.58milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Dog
-
-
Intravenous use
-
Dog
-
Horse
-
Meat and offal0day
-
Milk0hour
-
-
Cat
-
-
Subcutaneous use
-
Dog
-
Cat
-
Meat and offal0day
-
Milk0hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN02AF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
United Kingdom (Northern Ireland)
Available in:
-
United Kingdom (Northern Ireland)
Package description:
- Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 1 x 10 ml
- Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 1 x 50 ml
- Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 10 x 10 ml
- Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 5 x 10 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Richter Pharma AG
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetviva Richter GmbH
Responsible authority:
- The Veterinary Medicines Directorate
Authorisation number:
- Vm 22080/4002
Date of authorisation status change:
Reference member state:
-
Austria
Procedure number:
- AT/V/0005/001
Concerned member states:
-
Belgium
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Iceland
-
Ireland
-
Latvia
-
Lithuania
-
Netherlands
-
Norway
-
Portugal
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: